Ryo Kobayashi

610 citations
52 papers · 357 indexed · h-index 13
Topics
Nausea and vomiting management (11 papers)Cancer Treatment and Pharmacology (7 papers)Neutropenia and Cancer Infections (6 papers)
Partner nations
JapanChinaIreland

In The Last Decade

Ryo Kobayashi

45 papers receiving 352 citations

Peers

Ryo Kobayashi
Comparison fields: 5 of 80
  • Oncology 121
  • Pulmonary and Respiratory Medicine 105
  • Physiology 79
  • Surgery 56
  • Otorhinolaryngology 38
Replace Ilkka Ilonen with:
Ilkka Ilonen Finland
Martin Reichert Germany
Mayako Uchida Japan
Manabu Okuyama Japan
Yukio Suga Japan
Toshiaki Nakamura Japan
Seokwoo Park South Korea
Aiham Qdaisat United States
Tikva Yermiahu Israel
Steffen Wolk Germany
Ryo Kobayashi relative to Ilkka Ilonen Finland Ilkka Ilonen's profile →
Citations per field
00.5×1.5×
Ilkka Ilonen · 1×
Citations per year

Countries citing papers authored by Ryo Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Ryo Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Kobayashi more than expected).

Fields of papers citing papers by Ryo Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Kobayashi. The network helps show where Ryo Kobayashi may publish in the future.

Co-authorship network of co-authors of Ryo Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Kobayashi. A scholar is included among the top collaborators of Ryo Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Kobayashi. Ryo Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 2
5 1
6 2
7 4
8 1
9 3
10 3
11 7
12 26
13 1
14 28
15 4
16 8
17 19
18 22
19 12
20 15

About Ryo Kobayashi

Ryo Kobayashi is a scholar working on Geriatrics and Gerontology, Otorhinolaryngology and Pharmacology, having authored 52 papers that have together received 357 indexed citations. Recurring topics across this work include Nausea and vomiting management (11 papers), Cancer Treatment and Pharmacology (7 papers) and Neutropenia and Cancer Infections (6 papers). The work is most often cited by research in Otorhinolaryngology (38 citations), Geriatrics and Gerontology (32 citations) and Oncology (121 citations). Ryo Kobayashi has collaborated with scholars based in Japan, China and Ireland. Frequent co-authors include Akio Suzuki, Yoshinori Itoh, Hironori Fujii, Hirotoshi Iihara, Kazuhiro Yoshida, Nobuhisa Matsuhashi, Tadashi Sugiyama, Hideki Hayashi, Takao Takahashi and Hisashi Tsurumi. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026